[HTML][HTML] Integrative analysis of multi-omics and genetic approaches—a new level in atherosclerotic cardiovascular risk prediction

…, AA Prokhorikhin, AO Konradi, EV Shlyakhto… - Biomolecules, 2021 - mdpi.com
Genetics and environmental and lifestyle factors deeply affect cardiovascular diseases, with
atherosclerosis as the etiopathological factor (ACVD) and their early recognition can …

Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive …

…, A Sedefdjian, F Sévenier, EV Shlyakhto… - Journal of …, 2008 - journals.lww.com
Background Recent studies have indicated a relationship between hypertension and cognitive
function but therapeutic trials of antihypertensive therapy on the prevention of cognitive …

[HTML][HTML] Effect of cholecalciferol supplementation on the clinical features and inflammatory markers in hospitalized COVID-19 patients: a randomized, open-label …

…, OV Kalinina, AS Golovkin, WB Grant, EV Shlyakhto - Nutrients, 2022 - mdpi.com
Recent studies showed that a low 25-hydroxyvitamin D (25(OH)D) level was associated with
a higher risk of morbidity and severe course of COVID-19. Our study aimed to evaluate the …

[HTML][HTML] Vitamin D intake may reduce SARS-CoV-2 infection morbidity in health care workers

…, WB Grant, OV Kalinina, EN Grineva, EV Shlyakhto - Nutrients, 2022 - mdpi.com
In the last 2 years, observational studies have shown that a low 25-hydroxyvitamin D (25(OH)D)
level affected the severity of infection with the novel coronavirus (COVID-19). This study …

[HTML][HTML] Low 25 (OH) D level is associated with severe course and poor prognosis in COVID-19

…, MA Vashukova, WB Grant, EV Shlyakhto - Nutrients, 2021 - mdpi.com
We evaluated associations between serum 25-hydroxyvitamin D [25(OH)D] level and severity
of new coronavirus infection (COVID-19) in hospitalized patients. We assessed serum 25(…

EURObservational research programme: the chronic ischaemic cardiovascular disease registry: Pilot phase (CICD-PILOT)

…, Z Olivari, E Van Belle, EV Shlyakhto… - European heart …, 2016 - academic.oup.com
Aims Chronic ischaemic cardiovascular disease (CICD) is a major cause of mortality and
morbidity worldwide. The primary objective of the CICD-Pilot registry was to describe the …

[HTML][HTML] Bromhexine hydrochloride prophylaxis of COVID-19 for medical personnel: a randomized open-label study

…, EY Vasilieva, AO Konradi, EV Shlyakhto - … on infectious diseases, 2022 - hindawi.com
Background. Bromhexine hydrochloride has been suggested as a TMPRSS2 protease
blocker that precludes the penetration of SARS-CoV-2 into cells. We aimed to assess the …

[HTML][HTML] Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity

…, EY Vasilyeva, EV Shlyakhto - Journal of Diabetes …, 2019 - hindawi.com
Rationale. It is well known that diabetes mellitus (DM) exacerbates the mechanisms underlying
atherosclerosis. Currently, glucagon-like peptide-1 receptor agonists (aGLP-1) have one …

[HTML][HTML] Vitamin D status and immune response in hospitalized patients with moderate and severe COVID-19

…, DA Lebedev, ES Bykova, AS Golovkin, EV Shlyakhto - Pharmaceuticals, 2022 - mdpi.com
A low 25-hydroxyvitamin D (25(OH)D) level is considered as an independent risk factor for
COVID-19 severity. However, the association between vitamin D status and outcomes in …

2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of …

…, F Ruschitzka, RE Schmieder, E Shlyakhto… - European heart …, 2018 - academic.oup.com
Aims The expression of GADD153 (growth arrest and DNA damage-inducible gene 153),
an apoptosis-regulated gene, increases during endoplasmic reticulum (ER) stress. How …